article thumbnail

Hidden genetic defects contain real risks for serious diseases

Scienmag

Genome test for consanguineous couples makes sense For the first time researchers from Hebrew University of Jerusalem, Radboudumc, Maastricht UMC+ and international colleagues have gained insight into the “hidden genetic defects” of the general European population.

article thumbnail

Why early participant engagement is now a top priority in genetic disease research

pharmaphorum

In 2016, scientists behind a study called the Resilience Project analysed genetic data from 589,000+ people and found 13 adults who carried genetic variants that should have resulted in serious – even deadly – childhood disease, but who were apparently healthy. Giving participants something in return.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Where is the promise for plant-based medicines? Part 3 

Drug Discovery World

In the third and final part of this series of articles focused on plant-based medicines, DDW’s Megan Thomas evaluates therapeutic breakthroughs using plant-based products in drug discovery. References [link] [link] [link] [link] The post Where is the promise for plant-based medicines?

article thumbnail

Researchers zero in on genetic connection to postpartum hemorrhage

Scienmag

CHICAGO – Researchers have identified genetic mutations that appear to protect women from severe bleeding after childbirth, a leading cause of maternal death. DNA, which carries genetic information in cells, contain biological instructions. A genetic mutation, which is a permanent […].

article thumbnail

Why have medicines progressed so little in the last decades?

Drug Discovery World

Why has there been so little progress in medicine? 7 Human biology-based research At Safer Medicines Trust, we believe that using human biology-based research is the best way to develop safe and effective treatments for patients. Rat Trap: The Capture of Medicine by Animal Research – and How to Break Free. BMJ Open Sci.

article thumbnail

Japanese regulator reviews first-line bladder cancer combination

Drug Discovery World

Astellas has submitted a supplemental new drug application (sNDA) in Japan for Padcev (enfortumab vedotin (genetical recombination)) with Keytruda (pembrolizumab (genetical recombination)) for the first-line treatment of advanced bladder cancer. The sNDA is based on results from the Phase III EV-302 clinical trial.

article thumbnail

Where is the promise for plant-based medicines? Part 1: Cannabis  

Drug Discovery World

In the first part of this series of articles focused on plant-based medicines, DDW’s Megan Thomas evaluates the use of medical cannabis in drug discovery. Medical cannabis is often a first-thought when regarding plant-based medicines, but there remains public scepticism, arguably due to the regulations relating to the substance.